Xencor | Driftsresultatet



Operating Profit Endring Dato
AbbVie USD -1490000000 5.32B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 2.31B 182M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
AstraZeneca USD 2.04B 731M 2024-12
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
J&J USD 3.89B 549M 2024-12
MacroGenics USD 54.19M 112.37M 2024-09
Merck USD 4.3B 369M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD -409000000 5.57B 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Xencor USD 4.05M 66.33M 2024-12



Xencor Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.